Ivax to market Qvar
Executive Summary
Ivax will market CFC-free asthma inhaler Qvar (beclomethasone dipropionate) in U.S. under licensing agreement with 3M. Ivax also gets non-exclusive worldwide license to certain 3M patents covering HFA formulations of various asthma drugs. 3M will manufacture Qvar under long-term contract. The product has been on the market since Oct. 2000...